Please login to the form below

Not currently logged in
Email:
Password:

Sanofi appoints Stefan Oelrich to its executive team

He joins as executive vice president, diabetes and cardiovascular

Stefan OelrichSanofi has appointed Stefan Oelrich as executive vice president, diabetes and cardiovascular (DCV) and he will also join the executive committee.

Oelrich has served as head of Sanofi’s global diabetes franchise since June 2016 and as acting head of the DCV North America business since July.

He has previously served as DCV Europe Region Head and Sanofi Europe Coordinator, and was involved in establishing the DCV global business unit since mid-2015.

Oliver Brandicourt, chief executive officer, Sanofi, said: “Stefan is a highly effective leader who has demonstrated his ability to deliver strong results during his tenure at Sanofi.

“As one of the architects of our diabetes and cardiovascular business unit, I am confident Stefan will succeed in driving our strategy forward in the coming years.”

Oelrich has previously held positions for Bayer, including general manager, vice president of marketing and senior vice president and general manager of its US Women’s Healthcare franchise.

13th October 2017

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...

Latest intelligence

Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?
What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
What everyone forgets about good organisational change in pharma
Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....
Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST...

Infographics